CYP24A1 and neoplasm: Sulfonamidohydrazones 5–29 were tested for their ability to inhibit four human (h) CA isoforms involved in crucial physiologic/pathologic processes: the cytosolic hCA I and II and the transmembrane, tumor-associated hCA IX and XII.